Identification of Estrogen-Responsive Genes by Complementary Deoxyribonucleic Acid Microarray and Characterization of a Novel Early Estrogen-Induced Gene: EEIG1

Molecular Endocrinology

Volumn 18, Issue 2, 2004, Pages 402-411

  Wang, Dong Yu ^a   Fulthorpe, Roberta ^a   Liss, Steven N ^b   Edwards, Elizabeth A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; PROTEIN SYNTHESIS INHIBITOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC IDENTIFICATION; GENETIC STRAIN; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MEDICAL EXAMINATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS;

BREAST NEOPLASMS; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PESTICIDES; PHYTOESTROGENS; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0842291432     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0202     Document Type: Article

References (30)

1. Clemons M, Goss P 2001 Mechanisms of disease - estrogen and the risk of breast cancer. N Engl J Med 344:276-285
2. Fox JE, Starcevic M, Kow KY, Burow ME, McLachlan JA 2001 Nitrogen fixation - endocrine disrupters and flavonoid signaling. Nature 413:128-129
3. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC 2002 Mechanisms of disease - production and actions of estrogens. N Engl J Med 346:340-352
4. Ali S, Coombes RC 2002 Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2:101-112
5. van't Veer L, Dai HY, van de Vijver MJ, He YD, Hart AM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
6. Finlin BS, Gau CL, Murphy GA, Shao HP, Kimel T, Seit, RS, Chiu YF, Botstein D, Brown PO, Tamanoi F, Andres DA, Perou CM 2001 RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276:42259-42267
7. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ 2002 Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1289-1295
8. Custodia N, Won SJ, Novillo A, Wieland M, Li C, Callard IP 2001 Caenorhabditis elegans as an environmental monitor using DNA microarray analysis. In: McLachlan JA, Guillette LJ, Iguchi, T, eds. Environmental hormones: the scientific basis of endocrine disruption. New York: Annals of the New York Academy of Sciences, vol 948: 32-42
9. Ghosh MG, Thompson DA, Weigel RJ 2000 PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60: 6367-6375
10. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P 1984 Sequence of the Ps2 messenger-RNA induced by estrogen in the human-breast cancer cell-line Mcf-7. Nucleic Acids Res 12:2861-2878
11. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM 2000 Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60:5977-5983
12. Kuang WW, Thompson DA, Hoch RV, Weigel RJ 1998 Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 26:1116-1123
13. Watanabe H, Suzuki A, Mizutani T, Khono S, Lubahn DB, Handa H, Iguchi T 2002 Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells 7:497-507
14. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori, T, Kiyama R, Hayashi S 2002 Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192
15. Welch RD, Gorski J 1999 Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology 140:3602-3608
16. Cheng CM, Cohen M, Wang J, Bondy CA 2001 Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J 15:907-915
17. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH 2001 Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307
18. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874
19. Hansske B, Thiel C, Lubke, T, Hasilik M, Honing S, Peters V, Heidemann PH, Hoffmann GF, Berger EG, von Figura K, Korner C 2002 Deficiency of UDP-galactose: N-acetyl-glucosamine β-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 109:725-733
20. Jiang YQ, Harlocker SL, Molesh DA, Dillon DC, Stolk JA, Houghton RL, Repasky EA, Badaro R, Reed SG, Xu JC 2002 Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 21:2270-2282
21. Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK, Liu ET 2002 Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 4:R3
22. Kremmidiotis G, Gardner AE, Settasatian C, Savoia A, Sutherland GR, Callen DF 2001 Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein. Genomics 76: 58-65
23. Legler J, Zeinstra LM, Schuitemaker F, Peter H, Lanser JB, Brouwer A, Vethaak AD, deVoogt P, Murk AJ, Burg B 2002 Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ Sci Technol 36:4410-4415
24. Sole M, Aida ML, Castillo M, Porte C, Pedersen KL, Barcelo D 2000 Estrogenicity determination in sewage treatment plants and surface waters from the Catalonian area (NE Spain). Environ Sci Technol 34:5076-5083
25. Jobling S 1998 Review of suggested testing methods for endocrine-disrupting chemicals. Pure Appl Chem 70: 1805-1827
26. Inadera H 2003 Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochem Biophys Res Commun 309:272-278
27. Banerjee S, Saxena N, Sengupta K, Banerjee SK 2003 17α-Estradiol- induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway. Biochem Biophys Res Commun 300:209-215
28. Fan SJ, Meng QH, Gao B, Grossman J, Yadegari M, Goldberg ID, Rosen EM 2000 Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 60:5635-5639
29. Gutendorf B, Westendorf J 2001 Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166:79-89
30. Goryachev AB, MacGregor PF, Edwards AM 2001 Unfolding microarray data. J Comput Biol 8:443-461